Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma

Anticancer Research

Volumn 31, Issue 5, 2011, Pages 1685-1690

  Silveira, Aparecida Perpetuo Fedossi ^a   Manoel Caetano, Fernanda Da Silva ^a   Aoki, Sérgio ^a   Yamasaki, Lílian Hiromi Tomonari ^a   Rahal, Paula ^a   Silva, Ana Elizabete ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Chronic esophagitis; Esophageal carcinoma; FHIT; Mutations; Polymorphisms; TP53

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CODON; COMPUTER PROGRAM; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ACID ANHYDRIDE HYDROLASES; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79958134839     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M et al: Genetic alterations in esophageal cancer. Surg Today 35: 7-18, 2005. (Pubitemid 40941123)
2. Muñoz N: Precursor lesions of oesophageal cancer in high-risk populations in Iran and China. Lancet 1: 876-879, 1982.
3. Castelletto R, Muñoz N, Landoni N, Jmelnitzky A, Crespi M, Belloni P et al: Pre-cancerous lesions of the oesophagus in Argentina: prevalence and association with tobacco and alcohol. Int J Cancer 51: 34-37, 1992.
4. Muñoz N: Le dépistage du cancer de l'oesophage est-il réalisable? Sem Hop 73: 633-635, 1997.
5. Brasileiro FG: Bogliolo Patologia. 7 ed. Rio de Janeiro: Guanabara Koogan. pp. 58-582, 2002.
6. Robbins SL and Cotran RS: Patologia: Bases Patológicas das Doenças. 7 ed. Rio de Janeiro: Elsevier, p. 1504, 2005.
7. Pajecki D, Zilberstein B, dos Santos MA, Quintanilha AG, Cecconello I and Gama-Rodrigues J: Microbiota do megaesôfago e carcinogênese. Arq Gastroenterol 40: 16-19, 2003.
8. Loviscek LF, Cenoz MC, Badaloni AE and Agarinakazato O: Early cancer in achalasia. Dis Esophagus 11: 239-247, 1998. (Pubitemid 29087926)
9. Mandard AM, Hainaut P and Hollstein M: Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutation Res 462: 335-342, 2000. (Pubitemid 30190239)
10. Li LY, Tang JT, Jia LQ, Li PW: Mutations of p53 gene exons 4-8 in human esophageal cancer. World J Gastroenterol 11: 2998-3001, 2005.
11. Stoner GD and Grupta A: Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22: 1737-1746, 2001.
12. Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K and Croce CM: FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol 3: 748-754, 2002. (Pubitemid 35446744)
13. Menin C, Santacatterina M, Zambon A, Montagna M, Parenti A, Ruol A et al: Anomalous transcripts and allelic deletions of the FHIT gene in Human esophageal cancer. Cancer Genet Cytogenet 119: 56-61, 2000.
14. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M et al: Allele loss and promoter hypermethylation of VLH, RAR-beta, RASSFlA, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 63: 3724-3728, 2003.
15. Sambrook J and Russel DW: Molecular Cloning: A Laboratory Manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press, pp. 6.4-6.11, 2001.
16. Saiki RK: The design and optimization of the PCR. In: Erlich HA (ed). PCR Technology - Principles and Applications for DNA Amplification. New York: Oxford University Press, pp. 7-16, 1992.
17. National Center for Biotechnology Information Genbank: U94788. Available from: http://www.ncbi.nlm.nih.gov.
18. Manoel-Caetano FS, Silveira AFP and Silva AE: Gene mutations in esophageal mucosa of Chagas disease patients. Anticancer Res 29: 1243-1248, 2009.
19. Orita M, Iwahana H, Kanazawa H, Hayashi K and Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86: 2766-2770, 1989. (Pubitemid 19112622)
20. Hall TA: Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41: 95-98, 1999.
21. Garcia-Escudero R, Martinez-Cruz AB, Santos M, Lorz C, Segrelles C, Garaulet G, Saiz-Ladera C, Costa C, Buitrago-Perez A, Duenas M and Paramio JM: Gene expression profiling of mouse p53-deficient epidermal carcinoma defines molecular determinants of human cancer malignancy. Mol Cancer 9: 193, 2010.
22. Gallo O, Sardi I, Pepe G, Franchi A, Attanasio M, Giusti B et al: Multiple primary tumors of multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene. Int J Cancer 82: 180-186, 1999.
23. Konishi M, Kikuchi-Yanoshita R, Tanaka K, Sato C, Tsuruta K, Maeda Y et al: Genetic changes and histopathological grades in human hepatocarcinomas. Jpn J Cancer Res 84: 893-899, 1993. (Pubitemid 23262451)
24. Breton J, Sichel F, Abbas A, Marnay J, Arsène D and Lechevrel M: Simultaneous use of DGGE and DHPLC to screen TP53 mutations in cancers of the esophagus and cardia from a European high incidence area (Lower Normandy, France). Mutagenesis 18: 299-306, 2003. (Pubitemid 36592425)
25. Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J et al: p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 218: 69-79, 2005. (Pubitemid 40082703)
26. Ito S, Ohga T, Saeki H, Nakamura T, Watanabe M, Tanaka S et al: p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis. Int J Cancer 113: 22-28, 2005.
27. Murtaza I, Mushtaq D, Margoob MA, Dutt A, Wani NA, Ahmad I et al: A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol 12: 4033-4037, 2006.
28. Egashira A, Morita M, Kakeji Y, Sadanaga N, Oki E, Honbo T et al: p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries. Cancer Sci 98: 1152-1156, 2007.
29. Munõz D and Day NE: Cancer Epidemiology and Prevention. 2nd ed. Oxford University Press: Oxford, New York, pp. 681-706, 1996.
30. Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Tajima K et al: Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers. Cancer Lett 167: 65-72, 2001. (Pubitemid 32373270)
31. Kaneko K, Katagiri A, Konishi K, Kurahashi T, Ito H, Kumekawa Y et al: Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus. Br J Cancer 96: 492-498, 2007. (Pubitemid 46215222)
32. Vos M, Adams CH, Victor TC and Helden PD: Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet 140: 23-30, 2003.
33. Granja F, Morari J, Morari EC, Correa LAC, Assumpção LVM and Ward LS: Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 270: 151-157, 2004.
34. Ferreira da Silva I, Koifman RJ, Quinto Santos Souza C, Ferreira de Almeida Neto O and Koifman S: TP53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of Brazilian women with cervical lesions. J Toxicol Environ Health A 73: 888-900, 2010.
35. Holtkamp N, Atallah I, Okuducu AF, Mucha J, Hartmann C, Mautner VF et al: MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors. Neoplasia 9: 671-677, 2007. (Pubitemid 47328086)
36. Pandith AA, Shah ZA, Khan NP, Rasool R, Afroze D, Yousuf A, Wani S and Siddiqi M: Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet Cytogenet 203: 263-268, 2010.
37. Kim HN, Yu L, Kim NY, Lee IK, Kim YK, Yang DH, Lee JJ, Shin MH, Park KS, Choi JS and Kim HJ: Association with TP53 codon 72 polymorphism and the risk of non-Hodgkin lymphoma. Am J Hematol 85: 822-824, 2010.
38. Gemma A, Hagiwara K, Ke Y, Burke LM, Khan MA, Nagashima M et al: FHIT mutations in human primary gastric cancer. Cancer Res 57: 1435-1437, 1997. (Pubitemid 27175556)
39. Willem P, Brown J and Schouten J: A novel approach to simultaneously scan genes at fragile sites. BMC Cancer 6: 1-12, 2006.
40. Lee EJ, Lee BB, Kim JW, Shim YM, Hoseok I, Han J et al: Aberrant methylation of fragile histidine triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma. Eur J Cancer 42: 972-980, 2006.
41. Kannan K, Munirajan AK, Bhuvarahamurthy V, Mohanprasad BKC, Shankar P and Shanmugam G: FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncol 36: 189-193, 2000.
42. Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R,Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM and Huebner K: Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 57: 504-512, 1997.
43. Wang J, Smith PJ, Krainer AR and Zang MQ: Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Res 33: 5053-5062, 2005. (Pubitemid 41487813)
44. Cecener G, Tunca B, Egeli U, Bekar A, Guler G, Tolunay S and Aksoy K: FHIT gene sequence variants and reduced Fhit protein expression in glioblastoma multiforme. Cell Mol Neurobiol 30: 301-307, 2010.
45. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS et al: Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314: 1930-1933, 2006.
46. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV et al: A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528, 2007.